Search Results - "Bostrom, B C"

Juvenile xanthogranuloma: Forms of systemic disease and their clinical implications by Freyer, David R., Kennedy, Rosemarie, Bostrom, Bruce C., Kohut, Gloria, Dehner, Louis P.

“…OBJECTIVE: Juvenile xanthogranuloma (JXG) with systemic (extracutaneous) involvement is a rare histiocytic disorder in which significant morbidity and…”
Get full text

Early response to therapy and outcome in childhood acute lymphoblastic leukemia a review by GAYNON, P. S, DESAI, A. A, TUBERGEN, D. G, UCKUN, F. M, BOSTROM, B. C, HUTCHINSON, R. J, LANGE, B. J, NACHMAN, J. B, REAMAN, G. H, SATHER, H. N, STEINHERZ, P. G, TRIGG, M. E

“…Early response to therapy is defined as the initial response prior to Day 28 of treatment, the conventional time of marrow evaluation. The number of reports…”
Get full text

Prognostic Impact of Trisomies of Chromosomes 10, 17, and 5 Among Children With Acute Lymphoblastic Leukemia and High Hyperdiploidy (> 50 Chromosomes) by HEEREMA, N. A, SATHER, H. N, GAYNON, P. S, UCKUN, F. M, SENSEL, M. G, ZHANG, T, HUTCHINSON, R. J, NACHMAN, J. B, LANGE, B. J, STEINHERZ, P. G, BOSTROM, B. C, REAMAN, G. H

“…Children with acute lymphoblastic leukemia (ALL) and high hyperdiploidy (> 50 chromosomes) have improved outcome compared with other ALL patients. We sought to…”
Get full text

Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: a Children's Cancer Group study by Uckun, F M, Gaynon, P S, Sensel, M G, Nachman, J, Trigg, M E, Steinherz, P G, Hutchinson, R, Bostrom, B C, Sather, H N, Reaman, G H

“…Leukemic cells from T-lineage acute lymphoblastic leukemia (ALL) patients are thought to originate from T-lymphocyte precursors corresponding to discrete…”
Get more information

Association of Chromosome Arm 9p Abnormalities With Adverse Risk in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Cancer Group by Heerema, Nyla A., Sather, Harland N., Sensel, Martha G., Liu-Mares, Wen, Lange, Beverly J., Bostrom, Bruce C., Nachman, James B., Steinherz, Peter G., Hutchinson, Raymond, Gaynon, Paul S., Arthur, Diane C., Uckun, Fatih M.

“…Cytogenetic abnormalities of chromosome arm 9p occur frequently in children with acute lymphoblastic leukemia (ALL). We analyzed 201 such cases (11%) in 1,839…”
Get full text

Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group by Bostrom, Bruce C., Sensel, Martha R., Sather, Harland N., Gaynon, Paul S., La, Mei K., Johnston, Katherine, Erdmann, Gary R., Gold, Stuart, Heerema, Nyla A., Hutchinson, Raymond J., Provisor, Arthur J., Trigg, Michael E.

“…Conventional therapy for childhood acute lymphoblastic leukemia (ALL) includes prednisone and oral 6-mercaptopurine. Prior observations suggested potential…”
Get full text

Duration of Hospitalization as a Measure of Cost on Children’s Cancer Group Acute Lymphoblastic Leukemia Studies by GAYNON, Paul S, BOSTROM, Bruce C, HUTCHINSON, Raymond J, LANGE, Beverly J, NACHMAN, James B, STEINHERZ, Peter G, SENSEL, Martha G, LEE, Mei K, STRAM, Daniel O, SATHER, Harland N

“…We used duration of hospitalization as a surrogate for cost and event-free survival as a measure of effectiveness to estimate the cost-effectiveness ratios of…”
Get full text

Allogeneic Bone Marrow Transplantation for Acute Nonlymphocytic Leukemia in First Remission by McGlave, Philip B., Haake, Robert J., Bostrom, Bruce C., Brunning, Richard, Hurd, David D., Kim, Tae H., Nesbit, Mark E., Vercellotti, Gregory M., Weisdorf, Daniel, Woods, William G., Ramsay, Norma K.C., Kersey, John H.

“…Seventy-three patients with acute nonlymphocytic leukemia in first complete remission (CR) have received allogeneic bone marrow transplantation (BMT) with…”
Get full text

Treatment of childhood lymphangiomas with interferon-α by REINHARDT, M. A, NELSON, S. C, SENCER, S. E, BOSTROM, B. C, KURACHEK, S. C, NESBIT, M. E

“…Nonsurgical treatment of lymphangiomas has shown limited efficacy and often carries unacceptable toxicities, demonstrating the need for a more effective, less…”
Get full text

Plasma pharmacokinetics and cerebrospinal fluid penetration of thioguanine in children with acute lymphoblastic leukemia : a collaborative Pediatric Oncology Branch, NCI, and Children's Cancer Group study by LOWE, Elizabeth S, KITCHEN, Brenda J, WIDEMANN, Brigitte C, BALIS, Frank M, MURPHY, Robert F, ADAMSON, Peter C, ERDMANN, Gary, STORK, Linda C, BOSTROM, Bruce C, HUTCHINSON, Ray, HOLCENBERG, John, REAMAN, Gregory H, WOODS, William, FRANKLIN, Janet

“…In preclinical studies, thioguanine (TG) has been shown to be more potent than the standard acute lymphoblastic leukemia (ALL) maintenance agent,…”
Get full text

Abnormalities of Chromosome Bands 13q12 to 13q14 in Childhood Acute Lymphoblastic Leukemia by HEEREMA, Nyla A, SATHER, Harland N, GAYNON, Paul S, UCKUN, Fatih M, SENSEL, Martha G, LEE, Mei K, HUTCHINSON, Raymond J, NACHMAN, James B, REAMAN, Gregory H, LANGE, Beverly J, STEINHERZ, Peter G, BOSTROM, Bruce C

“…Little is known about nonrandom deletions of chromosome bands 13q12 to 13q14 (13q12-14) in acute lymphoblastic leukemia (ALL). We determined the prognostic…”
Get full text

Clinical Significance of Deletions of Chromosome Arm 6q in Childhood Acute Lymphoblastic Leukemia: A Report from the Children's Cancer Group by Heerema, Nyla A., Sather, Harland N., Sensel, Martha G., Lee, Mei K., Hutchinson, Raymond, Lange, Beverly J., Bostrom, Bruce C., Nachman, James B., Steinherz, Peter G., Gaynon, Paul S., Uckun, Fatih M.

“…We have compared outcome for 167 (9.0%) children with a del(6q) and 1713 (91%) children without a del(6q) treated on Children's Cancer Group (CCG)…”
Get full text

High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group by Dunkel, I J, Boyett, J M, Yates, A, Rosenblum, M, Garvin, Jr, J H, Bostrom, B C, Goldman, S, Sender, L S, Gardner, S L, Li, H, Allen, J C, Finlay, J L

“…Medulloblastoma is a highly lethal disease when it recurs. Very few patients survive with conventional treatment. This study evaluated the use of high-dose…”
Get more information

Prospective, randomized, double-blind, placebo-controlled comparison of metoclopramide and ondansetron for prevention of posttonsillectomy or adenotonsillectomy emesis by Stene, Erik N., Seay, Russell E., Young, Laurie A., Bohnsack, Lois E., Bostrom, Bruce C.

“…Study Objective: To compare the antiemetic efficacy of prophylactic ondansetron, metoclopramide, and placebo for prevention of postoperative vomiting in…”
Get full text

Reversed-phase high-performance liquid chromatographic approach to determine total lymphocyte concentrations of 6-thioguanine, methylmercaptopurine and methylthioguanine in humans by Erdmann, G R, Steury, J C, Carleton, B C, Stafford, R J, Bostrom, B C, Canafax, D M

“…A reversed-phase high-performance liquid chromatographic (HPLC) procedure was developed to quantify intracellular lymphocyte 6-thioguanine,…”
Get more information

Comparison of neurobehavioral outcomes in survivors of childhood acute lymphoblastic leukemia (ALL) previously randomized to intrathecal methotrexate vs. intrathecal methotrexate/hydrocortisone/cytarabine by Kadan-Lottick, N. S., Brouwers, P., Kaleita, T. A., Breiger, D., Stork, L. C., Bostrom, B. C., Neglia, J. P.

“…Abstract only…”
Get full text

A reversed phase high performance liquid chromatography approach in determining total red blood cell concentrations of 6-thioguanine, 6-mercaptopurine, methylthioguanine, and methylmercaptopurine in a patient receiving thiopurine therapy by Erdmann, G R, France, L A, Bostrom, B C, Canafax, D M

“…A reversed phase high performance liquid chromatographic procedure was developed to quantify 6-thioguanine, 6-mercaptopurine, methylthioguanine, and…”
Get more information

A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a children's Cancer Group Study by AVRAMIS, Vassilios I, SENCER, Susan, HILDEN, Joanne M, LANGE, Beverly, MAJLESSIPOUR, Fataneh, MATHEW, Pracad, NEEDLE, Michael, NEGLIA, Joseph, REAMAN, Gregory, HOLCENBERG, John S, PERICLOU, Antonia P, SATHER, Harland, BOSTROM, Bruce C, COHEN, Lewis J, ETTINGER, Alice G, ETTINGER, Lawrence J, FRANKLIN, Janet, GAYNON, Paul S

“…For this study, 118 children with standard-risk acute lymphoblastic leukemia (ALL) were given randomized assignments to receive native or pegylated Escherichia…”
Get full text

Treatment of newly diagnosed children with lower-risk leukemia: A collaborative Children’s Cancer Group (CCG)/NCI pilot trial incorporating 6-thioguanine by Jacobs, S. S., Stork, L., Bostrom, B. C., Hutchinson, R., Holcenberg, J., Reaman, G. H., Erdman, G. R., Franklin, J. L., Steinberg, S. M., Adamson, P. C.

“…Abstract only…”
Get full text

Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group by Lange, Beverly J., Bostrom, Bruce C., Cherlow, Joel M., Sensel, Martha G., La, Mei K.L., Rackoff, Wayne, Heerema, Nyla A., Wimmer, Robert S., Trigg, Michael E., Sather, Harland N.

“…Addition of a delayed-intensification (DI) phase after standard induction/consolidation therapy was previously shown to improve outcome for patients younger…”
Get full text